Published in Can Respir J on December 17, 2003
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrob Agents Chemother (2013) 0.77
Diffuse panbronchiolitis. CMAJ (2012) 0.75
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J (2006) 3.27
Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43
Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med (2014) 2.00
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada. Environ Health Perspect (2009) 1.77
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med (2006) 1.71
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study. Chest (2010) 1.49
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization rates. Chest (2006) 1.38
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med (2013) 1.19
What do we know about asthma triggers? a review of the literature. J Asthma (2012) 1.06
Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD. COPD (2012) 1.04
Variations and gaps in management of acute asthma in Ontario emergency departments. Chest (2008) 0.97
The coming of age of asthma guidelines. Lancet (2008) 0.96
Assessment of a medication-based asthma index for population research. Am J Respir Crit Care Med (2002) 0.95
Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma. Ann Allergy Asthma Immunol (1997) 0.94
Cocaine induced eosinophilic lung disease. Thorax (1992) 0.93
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology (2012) 0.88
Profile of eicosanoids in breath condensate in asthma and COPD. J Breath Res (2012) 0.87
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest (2003) 0.86
Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma (2006) 0.85
Omalizumab for asthma: pharmacology and clinical profile. Expert Rev Respir Med (2009) 0.84
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries. J Asthma (2013) 0.84
Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med (2005) 0.83
Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J (2012) 0.83
The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med (2008) 0.82
Economic issues in the use of office spirometry for lung health assessment. Can Respir J (2003) 0.82
The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract (2007) 0.82
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease. CMAJ (2012) 0.82
Dynamic airway evaluation with volume CT: initial experience. Can Assoc Radiol J (2010) 0.82
Evaluation of a questionnaire to assess compliance with anti-asthma medications. J Asthma (2004) 0.81
Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol (2003) 0.81
Parent-reported symptoms may not be adequate to define asthma control in children. Pediatr Pulmonol (2007) 0.80
Thoracic actinomycosis in a patient with pulmonary involvement caused by non-Hodgkin's lymphoma. Clin Infect Dis (1996) 0.80
Tiotropium and simplified detection of dynamic hyperinflation. Chest (2007) 0.79
Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction. Int J Gen Med (2010) 0.79
Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario. Can Respir J (2011) 0.78
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study. BMC Clin Pharmacol (2010) 0.78
SMART isn't. J Allergy Clin Immunol (2010) 0.76
Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. Respir Med (2009) 0.76
A step forward in COPD management: reading between the lines. Chest (2012) 0.75
Predicting the need for supplemental oxygen during airline flight in patients with chronic pulmonary disease: a comparison of predictive equations and altitude simulation. Can Respir J (2009) 0.75
A Randomized Controlled Trial to Determine the Effect of Inhaled Corticosteroid on Intraocular Pressure in Open-Angle Glaucoma and Ocular Hypertension: The ICOUGH Study. J Glaucoma (2017) 0.75
Asthma controller delay and recurrence risk after an emergency department visit or hospitalization. Respir Med (2012) 0.75
Cavitary aspergillosis as a complication of AIDS. Can Assoc Radiol J (1993) 0.75
Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone. Can J Cardiol (1993) 0.75
Prognosis in a patient with an initial normal pulmonary angiogram. Chest (1994) 0.75
Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management. COPD (2015) 0.75
Hypersensitivity pneumonitis with normal high resolution computed tomography scans. Can Respir J (2001) 0.75
Seretide: a pharmacoeconomic analysis. J Med Econ (2008) 0.75